ReviewProbiotics and antimicrobial proteins2026
Targeting the Gut Microbiota with Pro- and Postbiotics: Emerging Strategies against Alopecia.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alopecia, which encompasses disorders such as androgenetic alopecia, alopecia areata, and telogen effluvium, is a complex condition influenced by genetic, hormonal, immunological, and environmental factors. Recent research has highlighted the importance of the gut-hair axis, whereby gut microbiota and their metabolites impact systemic immunological balance, oxidative stress, and nutritional bioavailability. Dysbiosis is associated with increased inflammation, impaired epithelial barrier function, and altered metabolite synthesis, which contribute to hair follicle shrinkage and a disruption of the hair cycle. Modulating gut microbiota with probiotics, prebiotics, postbiotics, synbiotics, and parabiotics has shown promise in preclinical and early clinical investigations. Probiotic strains, including Lactobacillus and Bifidobacterium, exhibit immunoregulatory, antioxidant, and barrier-enhancing properties. Similarly, postbiotic metabolites, such as short-chain fatty acids, bacteriocins, and exopolysaccharides, have shown anti-inflammatory and cytoprotective activities. Furthermore, nutritional components influence microbial communities to enhance hair health. Although, additional randomized controlled studies are necessary, microbiota-targeted approaches represent an innovative paradigm in alopecia treatment, advancing towards individualized, root-cause-driven therapies.
Indexed as
Identifiers
41706407What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.